Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancers|March 28, 2024
Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020Robert C Hsu, Kai-Ya Tsai, David J Benjamin, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Isavuconazole in the Treatment of Coccidioidal MeningitisArash Heidari, Miriam Quinlan, David J Benjamin, et al.
European Urology Open Science|January 5, 2023
Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational StudyArash Rezazadeh Kalebasty, David J Benjamin, Yohann Loriot, et al.
The Patient|August 28, 2024
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional ThresholdingAndrea B Apolo, Christine Michaels-Igbokwe, Nicholas I Simon, et al.
Radiology|December 9, 2025
61Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of 61Cu-labeled PET RadiotracersGary A Ulaner, Jeffrey C Bassett, Ryan Reddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel DiseaseHamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
The Oncologist|April 8, 2015
The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experienceRichard M Bambury, David J Benjamin, Joshua L Chaim, et al.
JTO Clinical and Research Reports|November 25, 2022
The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective StudyDavid J Benjamin, Shuai Chen, Joanna B Eldredge, et al.
F1000Research|November 3, 2020
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 daysPerrine Janiaud, Cathrine Axfors, Janneke Van't Hooft, et al.
European Urology Oncology|January 11, 2021
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint InhibitorsAli Raza Khaki, Ang Li, Leonidas N Diamantopoulos, et al.
Pageof 9